Daunorubicin derivatives

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 17A, A61K 3170, C07G 1100

Patent

active

042255899

ABSTRACT:
Daunorubicin derivatives of the formula: ##STR1## wherein R.sub.1 represents a group of the formula: ##STR2## in which (i) X.sub.1 and X.sub.2 both represent oxygen or both represent sulphur and the symbols R.sub.3 each represent alkyl of 1 through 4 carbon atoms, phenyl or phenyl substituted in the para-position by methyl, methoxy or methylthio, or together form an alkylene radical of 2 through 4 carbon atoms, or (ii) one of X.sub.1 and X.sub.2 represents oxygen and the other represents sulphur and the symbols R.sub.3 together form an alkylene radical of 2 through 4 carbon atoms, and R.sub.4 represents hydrogen, alkyl of 1 through 4 carbon atoms or phenyl, and R.sub.2 represents hydrogen or trifluoroacetyl, are new compounds possessing anti-tumour properties.

REFERENCES:
patent: 4031211 (1977-06-01), Patelli et al.
American Druggist, May 19, 1969, (Pharm. & Med. Science, pp. 33-34). _
Journ. Med. Chem., 1974, vol. 17, No. 3, pp. 335-337. _
Experientia 26, 4, pp. 389-390 (1970). _
Merck Index, 9th Edition, 1976, No. 3428. _

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Daunorubicin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Daunorubicin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Daunorubicin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1169532

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.